Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126352741 | 12635274 | 1 | I | 2016 | 20160727 | 20160808 | 20160808 | EXP | FR-AFSSAPS-AN20160799 | FR-FRI-1000086694 | FOREST | 0.00 | M | Y | 0.00000 | 20160808 | OT | DK | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126352741 | 12635274 | 1 | PS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG | 21323 | 10 | MG | FILM-COATED TABLET | QD | ||||||
| 126352741 | 12635274 | 2 | I | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 75 MG | Y | 0 | 75 | MG | POWDER FOR ORAL SOLUTION | QD | |||||
| 126352741 | 12635274 | 3 | I | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG | Y | 0 | 75 | MG | QD | ||||||
| 126352741 | 12635274 | 4 | C | BISOPROLOL | BISOPROLOL | 1 | 1 DF | 0 | 1 | DF | TABLET | QD | |||||||
| 126352741 | 12635274 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 1 DF | 0 | 1 | DF | QD | ||||||||
| 126352741 | 12635274 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 1 DF | 0 | 1 | DF | TABLET | QD | |||||||
| 126352741 | 12635274 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 1 DF | 0 | 1 | DF | TABLET | QD | |||||||
| 126352741 | 12635274 | 8 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 1 DF | 0 | 1 | DF | QD | ||||||||
| 126352741 | 12635274 | 9 | C | XATRAL LP | ALFUZOSIN | 1 | 1 DF | 0 | 1 | DF | TABLET | QD | |||||||
| 126352741 | 12635274 | 10 | C | DOLIPRANE | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 126352741 | 12635274 | 11 | C | METHOTREXATE. | METHOTREXATE | 1 | 5.71 MG | 0 | 40 | MG | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126352741 | 12635274 | 1 | Depressive symptom |
| 126352741 | 12635274 | 2 | Vascular device user |
| 126352741 | 12635274 | 3 | Vascular device user |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126352741 | 12635274 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126352741 | 12635274 | Anaemia | |
| 126352741 | 12635274 | Drug interaction | |
| 126352741 | 12635274 | Epistaxis | |
| 126352741 | 12635274 | Melaena |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126352741 | 12635274 | 2 | 20160505 | 0 | ||
| 126352741 | 12635274 | 3 | 20160505 | 0 |